EGFR and ductal breast carcinoma in situ: Furthermore, in a study of 266 primary DCIS with a known recurrence [22, 23], we have seen that primary DCIS lesions with a subsequent invasive IBE were more often ER-positive, HER2-negative, and EGFR-negative, compared to primary DCIS with a subsequent in situ IBE.